Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD

14.85  +0.76 (+5.39%)

After market: 14.85 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLB. CLB was compared to 59 industry peers in the Energy Equipment & Services industry. CLB has only an average score on both its financial health and profitability. CLB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CLB was profitable.
CLB had a positive operating cash flow in the past year.
Of the past 5 years CLB 4 years were profitable.
In the past 5 years CLB always reported a positive cash flow from operatings.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CLB has a better Return On Assets (5.32%) than 61.02% of its industry peers.
With a decent Return On Equity value of 12.46%, CLB is doing good in the industry, outperforming 66.10% of the companies in the same industry.
CLB's Return On Invested Capital of 9.83% is fine compared to the rest of the industry. CLB outperforms 74.58% of its industry peers.
CLB had an Average Return On Invested Capital over the past 3 years of 8.80%. This is in line with the industry average of 8.07%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.32%
ROE 12.46%
ROIC 9.83%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

CLB has a Profit Margin (5.99%) which is in line with its industry peers.
CLB's Profit Margin has declined in the last couple of years.
CLB's Operating Margin of 11.60% is fine compared to the rest of the industry. CLB outperforms 62.71% of its industry peers.
CLB's Operating Margin has declined in the last couple of years.
CLB's Gross Margin of 19.72% is on the low side compared to the rest of the industry. CLB is outperformed by 69.49% of its industry peers.
In the last couple of years the Gross Margin of CLB has declined.
Industry RankSector Rank
OM 11.6%
PM (TTM) 5.99%
GM 19.72%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
The number of shares outstanding for CLB has been increased compared to 5 years ago.
The debt/assets ratio for CLB has been reduced compared to a year ago.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.08 indicates that CLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of CLB (3.08) is better than 77.97% of its industry peers.
CLB has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as CLB would need 2.91 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.91, CLB is doing good in the industry, outperforming 64.41% of the companies in the same industry.
CLB has a Debt/Equity ratio of 0.50. This is a neutral value indicating CLB is somewhat dependend on debt financing.
The Debt to Equity ratio of CLB (0.50) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.91
Altman-Z 3.08
ROIC/WACC1.09
WACC8.99%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

CLB has a Current Ratio of 2.32. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.32, CLB is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
CLB has a Quick Ratio of 1.71. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CLB (1.71) is better than 67.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.71
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

CLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.64%, which is quite good.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.14% yearly.
The Revenue has been growing slightly by 2.75% in the past year.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)8.64%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%15.79%
Revenue 1Y (TTM)2.75%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.8%

3.2 Future

The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y4.19%
EPS Next 2Y9.19%
EPS Next 3Y9.05%
EPS Next 5Y12.78%
Revenue Next Year4.2%
Revenue Next 2Y3.05%
Revenue Next 3Y3.06%
Revenue Next 5Y3.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.88, CLB is valued correctly.
The rest of the industry has a similar Price/Earnings ratio as CLB.
When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (29.35), we can say CLB is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.20, CLB is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as CLB.
CLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.88
Fwd PE 16.2
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLB is valued more expensive than 81.36% of the companies in the same industry.
CLB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.04
EV/EBITDA 10.6
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.02
PEG (5Y)N/A
EPS Next 2Y9.19%
EPS Next 3Y9.05%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.28%, CLB is not a good candidate for dividend investing.
In the last 3 months the price of CLB has falen by -23.37%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.85, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

The dividend of CLB decreases each year by -55.13%.
CLB has been paying a dividend for at least 10 years, so it has a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

5.97% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.97%
EPS Next 2Y9.19%
EPS Next 3Y9.05%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CORE LABORATORIES INC

NYSE:CLB (3/7/2025, 8:15:03 PM)

After market: 14.85 0 (0%)

14.85

+0.76 (+5.39%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)01-29 2025-01-29/amc
Earnings (Next)N/A N/A
Inst Owners112.55%
Inst Owner Change0.32%
Ins Owners0.98%
Ins Owner Change3.49%
Market Cap695.43M
Analysts46.67
Price Target19.38 (30.51%)
Short Float %13.07%
Short Ratio18.45
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.97%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-10 2025-02-10 (0.01)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.44%
Min EPS beat(2)-0.26%
Max EPS beat(2)7.15%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-0.26%
Max EPS beat(4)20.48%
EPS beat(8)5
Avg EPS beat(8)6.61%
EPS beat(12)7
Avg EPS beat(12)3.99%
EPS beat(16)8
Avg EPS beat(16)3.03%
Revenue beat(2)0
Avg Revenue beat(2)-2.05%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)-0.73%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)3.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)2
Avg Revenue beat(12)-1.48%
Revenue beat(16)3
Avg Revenue beat(16)-1.61%
PT rev (1m)0%
PT rev (3m)-1.48%
EPS NQ rev (1m)-14.42%
EPS NQ rev (3m)-27.38%
EPS NY rev (1m)-6.6%
EPS NY rev (3m)-7.36%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)-3.35%
Revenue NY rev (1m)-0.78%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 16.2
P/S 1.33
P/FCF 16.04
P/OCF 12.33
P/B 2.76
P/tB 4.76
EV/EBITDA 10.6
EPS(TTM)0.88
EY5.93%
EPS(NY)0.92
Fwd EY6.17%
FCF(TTM)0.93
FCFY6.24%
OCF(TTM)1.2
OCFY8.11%
SpS11.19
BVpS5.38
TBVpS3.12
PEG (NY)4.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.32%
ROE 12.46%
ROCE 12.33%
ROIC 9.83%
ROICexc 10.23%
ROICexgc 13.17%
OM 11.6%
PM (TTM) 5.99%
GM 19.72%
FCFM 8.28%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexcg growth 3Y11.32%
ROICexcg growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.91
Debt/EBITDA 1.67
Cap/Depr 87.13%
Cap/Sales 2.49%
Interest Coverage 5.6
Cash Conversion 74.47%
Profit Quality 138.09%
Current Ratio 2.32
Quick Ratio 1.71
Altman-Z 3.08
F-Score6
WACC8.99%
ROIC/WACC1.09
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%15.79%
EPS Next Y4.19%
EPS Next 2Y9.19%
EPS Next 3Y9.05%
EPS Next 5Y12.78%
Revenue 1Y (TTM)2.75%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.8%
Revenue Next Year4.2%
Revenue Next 2Y3.05%
Revenue Next 3Y3.06%
Revenue Next 5Y3.47%
EBIT growth 1Y5.76%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year35.46%
EBIT Next 3Y21.01%
EBIT Next 5Y17.46%
FCF growth 1Y205.14%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y127.47%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%